![The Nicotiana benthamiana tobacco plant is increasingly used for the production of high-value, biologically active molecules. [Wiki Commons]](https://www.genengnews.com/wp-content/uploads/2024/12/Nicotiana_benthamiana_leaf.jpg "Nicotiana_benthamiana_leaf")
France-based Samabriva opened a new 1,400 m² biomanufacturing facility in Liege, Belgium. The multi-million Euro investment is designed to provide industrial scale production of high value natural molecules used in the manufacture of pharmaceutical products.
Samabriva is a plant-based biotechnology company that has developed an automated, proprietary bioproduction system available to companies who want to produce molecules including natural molecules from plants and recombinant proteins, according to Pascal Lizin, chairman of the board.
“This new facility represents a significant milestone for Samabriva. It emphasizes our commitment to delivering plant-based bioproduction at large scale,” says Lizin. “By offering control over the entire value chain, the facility has the potential to transform production of high value molecules, delivering them more cost effectively to international customers, when and where they’re needed.”
Equipped with Samabriva’s bioreactors, which have been specifically designed to maximize production in hairy root culture, the facility is designed to enhance efficiency and output, continues Lizin, who adds that phase one of the facility is expected to be operational by Q1 2025.
